Leukocyte Reduction Should Be Done Prior To Transfusions - FDA Safety Alert
This article was originally published in The Gray Sheet
Executive Summary
Blood products that are leukocyte-reduced at the time of collection or during the laboratory storage period should be used for all patients requiring leukocyte-reduced blood products "whenever feasible," FDA says in a May 4 safety alert.